NCT00785915View on ClinicalTrials.gov

AZD6765 Single and Multiple Ascending Dose Study in Healthy Male and Female Japanese and Caucasian Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

November 30, 2008

Primary Completion Date

March 31, 2009

Study Completion Date

March 31, 2009

Conditions
Healthy
Interventions
DRUG

AZD6765

single administration and once daily for 5 days

DRUG

Placebo

single administration and once daily for 5 days

Trial Locations (2)

Unknown

Research Site, Glendale

Research Site, Baltimore

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY